Tobira Therapeutics

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Tobira Therapeutics - overview

Established

2006

Location

South San Francisco, CA, US

Primary Industry

Pharmaceuticals

About

Established in 2006, Tobira Therapeutics is a biopharmaceutical company based in California, US. The firm engages in the development and commercialization of antiviral compounds for HIV treatment.


Current Investors

Domain Associates, Frazier Healthcare Partners, Canaan Partners

Primary Industry

Pharmaceuticals

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.tobiratherapeutics.com

Total Amount Raised

Subscriber access only

Tobira Therapeutics - financials

Fiscal Year EndedDec 31, 2013Dec 31, 2014Dec 30, 2015
Revenue (USD)---
% Revenue Growth (YoY)---
EBITDA (USD)---
Operating Income (USD)---
Operating Margin---
% EBITDA Margin---
NET Income (USD)---
% Net Margin---

Tobira Therapeutics - key contacts

NamePositionStart DateEnd DateVcardBio 
Member of Board of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.